Clinical Trial Update: Identifying Sleep Apnea Patients That Best Respond to Atomoxetine Plus Oxybutynin Therapy [Phase 1, Phase 2]

View source ↗

Summary

Early-phase clinical trial investigating atomoxetine plus oxybutynin to identify which sleep apnea patients respond best.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Atomoxetine (Atomoxetine)
• oxybutynin (oxybutynin)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Obstructive Sleep Apnea | Phase 1, Phase 2 | Status: UNKNOWN